A surgical stapler joins or resects tissue by firing rows of staples, replacing hand-sewn sutures in many procedures — and the staples themselves remain implanted. Because the device performs a critical surgical function and leaves an implant behind, CDSCO regulates surgical staplers as a Class C device with mechanical performance, biocompatibility and sterility behind the licence. This guide covers the full CDSCO pathway for surgical staplers under the Medical Devices Rules, 2017 — classification, licence route, the standards, the documents, the fees and the timeline.
📌 Under the Medical Devices Rules, 2017, Surgical Staplers are a notified medical device and cannot be manufactured, imported or sold in India without a CDSCO licence. As a Class C device (moderate-to-high risk), a domestic manufacturer applies in Form MD-7 to the Central Licensing Authority (CDSCO headquarters) and receives the licence in Form MD-9; an importer applies in Form MD-14 through an Indian Authorised Agent and receives an import licence in Form MD-15 from the Central Licensing Authority. The licence must be in hand before the product is made or the first consignment lands.
📋 Is a CDSCO Licence Mandatory for Surgical Staplers?
Yes. A surgical stapler is a notified Class C medical device and cannot be manufactured, imported or sold in India without a CDSCO licence. Because it is Class C, a domestic manufacturer applies to the Central Licensing Authority in Form MD-7 for a Form MD-9 licence; an importer applies in Form MD-14 for a Form MD-15 import licence. Linear, circular, skin and powered/endoscopic staplers, with their reload cartridges, are declared with the system.
🧭 Risk Classification of Surgical Staplers
Every medical device in India is placed in one of four risk classes under the First Schedule of the Medical Devices Rules, 2017. The class is the single most important decision in the whole application — it fixes which authority you file with, which form you use, the fee, the audit route and the timeline.
Surgical Staplers are classified as Class C. A surgical stapler performs a critical tissue-joining function and leaves implanted staples in the body, which places it in Class C (moderate-to-high risk) under the First Schedule. Classification follows the CDSCO classification list for the relevant medical-device category read with the First Schedule rules; where a device could fall in two classes, the higher class applies, and an accessory is classified in its own right.
🪪 Which CDSCO Licence You Need for Surgical Staplers
There are two distinct routes, and which one applies depends on whether you make the device in India or bring it in from overseas:
- To manufacture surgical staplers in India (Class C) — apply in Form MD-7 to the Central Licensing Authority (CDSCO headquarters); the licence is granted in Form MD-9. A CDSCO joint audit team inspects the manufacturing site before the licence is granted — site inspection is mandatory for Class C and D.
- To import surgical staplers (any class) — the overseas manufacturer appoints an Indian Authorised Agent who holds a valid manufacturing or wholesale licence, and the agent files Form MD-14 with the Central Licensing Authority. The import licence is granted in Form MD-15 and names the manufacturer, each site and every device covered.
- To import a small quantity for testing, evaluation, demonstration or clinical investigation — a separate test licence is used: Form MD-12 application, Form MD-13 licence.
- Loan licence — a manufacturer using another licensee's approved premises applies in Form MD-4 (Class A/B) or Form MD-8 (Class C/D) for a loan licence in Form MD-6 or MD-10.
📘 Applicable Standards for Surgical Staplers
Surgical staplers are evaluated on mechanical performance plus implant-material biocompatibility and sterility:
- Mechanical performance testing — staple formation, firing force, line integrity and leak/burst of the staple line.
- ISO 5832 series — the implantable metal of the staples (e.g. titanium).
- ISO 10993 series — biocompatibility of the staples and tissue-contacting parts.
- ISO 11135 / 11137 — sterilisation validation.
- IEC 60601-1 / -1-2 — for powered (electromechanical) staplers.
- Reload/cartridge compatibility evidence.
🗂️ The Core Technical Dossier — Required for Every Application
Whether you file for a manufacturing licence or an import licence, CDSCO expects the same backbone of technical evidence built around the device. Getting this base right is what decides whether the file clears in one review cycle or comes back as a deficiency letter; the device-specific documents in the next section sit on top of it.
- Covering letter and application form — Form MD-3 / MD-7 (manufacture) or Form MD-14 (import), completed on the CDSCO Medical Device Online (SUGAM) portal, stating every device, variant and site.
- Device Master File (DMF) — the heart of the dossier: device description and intended use, materials, design and manufacturing information, risk management (ISO 14971) file, verification and validation data, sterilisation validation where applicable, shelf-life and stability data, and the Essential Principles checklist.
- Plant Master File (PMF) — the site: layout, equipment, utilities, HVAC and water systems, organisation chart with the competent technical staff, and the quality-system procedures that govern production.
- ISO 13485 Quality Management System certificate — a current QMS certificate for the manufacturing site, with the scope covering the device.
- Essential Principles of Safety and Performance — a completed checklist mapping the device against each applicable essential principle, with the standard or evidence relied on for each.
- Risk management file — an ISO 14971 risk analysis identifying hazards, risk controls and residual-risk justification for the device.
- Test / performance reports — reports against the applicable BIS/IS or ISO/IEC standards for the device, from an accredited laboratory.
- Labels, Instructions for Use (IFU) and packaging — artwork that meets the labelling requirements of the Medical Devices Rules, including manufacturer, licence number, sterile status and single-use symbols where relevant.
- Undertaking and declaration — that the device conforms to the Essential Principles and the applicable standards, signed by the authorised signatory.
- Fee receipt — the government fee paid online through the CDSCO portal / Bharatkosh.
➕ Device-Specific Documents for Surgical Staplers
On top of the core dossier, a surgical-stapler file should carry:
- Mechanical test reports — staple formation (B-shape), firing force, staple-line integrity and leak/burst.
- Implant-material certificates and biocompatibility (ISO 10993) for the staples.
- Sterilisation validation with the sterility assurance level.
- Reload-cartridge compatibility and colour-coding evidence.
- Electrical-safety evidence for powered staplers.
- Country-of-origin approval / Free Sale Certificate for imports.
For an import licence (Form MD-14) there are three further essentials on top of the dossier above:
- Free Sale Certificate (FSC) — issued by the National Regulatory Authority of the country of origin, showing the device is freely sold there; not older than the period CDSCO accepts, and legalised (apostille or embassy attestation).
- Country-of-origin regulatory approval — e.g. US FDA 510(k)/PMA, EU CE certificate, or equivalent, evidencing marketing clearance in a reference market.
- Power of Attorney and Authorised Agent licence — a notarised, legalised Power of Attorney from the manufacturer to the Indian Authorised Agent, and the agent's valid wholesale or manufacturing licence.
🏭 QMS & Essential Principles — What CDSCO Checks
The Medical Devices Rules, 2017 are built on two pillars, and both are assessed for surgical staplers:
- Essential Principles of Safety and Performance (Fifth Schedule) — the device must be safe and perform as intended, with risks reduced as far as possible and acceptable against its benefit. Conformity is shown by meeting recognised standards and by the risk-management file.
- Quality Management System (ISO 13485) — design controls, purchasing and supplier control, process validation, traceability, complaint handling and CAPA must be in place and evidenced at audit.
- Risk management (ISO 14971) — a living file, not a one-off document; residual risks must be justified and communicated in the IFU.
- Clinical evidence — proportionate to the class: a clinical evaluation report drawing on literature and equivalence for lower-risk devices, and clinical investigation data for many Class C/D and novel devices.
🏷️ Surgical Staplers Label & IFU Requirements
Surgical-stapler labelling is checked for staple size, compatibility and sterility:
- Stapler type (linear/circular/skin), staple size/leg length and the reference number.
- Manufacturer name and address, and the CDSCO licence number.
- Batch/lot number, date of manufacture and use-by date.
- "STERILE" with the sterilisation-method symbol and a single-use symbol.
- Compatible reload cartridges (with colour code) and tissue-thickness guidance in the IFU.
⚖️ Stapler, Reloads and the Implanted Staples
A surgical stapler is used with reload cartridges, and the staples it fires stay in the patient — so the file spans both the mechanical device and the implanted staple material. Mismatched reloads or the wrong staple height for the tissue thickness is a known cause of staple-line failure, so CDSCO expects reload-compatibility and tissue-thickness evidence, plus biocompatibility for the staples. Declare the stapler with its compatible reloads and evidence both the mechanism and the implant. Settle this scope before drafting.
🛠️ Step-by-Step Registration Process
- Confirm the classificationFix the risk class against the CDSCO classification list and the First Schedule — this decides the form, the authority, the fee and the audit route before anything else is drafted.
- Choose the routeManufacturing (Form MD-3 / MD-7) or import (Form MD-14). Importers appoint an Indian Authorised Agent holding a valid manufacturing or wholesale licence.
- Build the Device Master File and Plant Master FileAssemble device description, materials, design and process data, ISO 14971 risk file, sterilisation and stability data, and the site file with the QMS.
- Complete the Essential Principles checklistMap the device against each applicable essential principle and cite the BIS/IS or ISO/IEC standard or test report relied on for each.
- Draw the test and performance reportsTest to the applicable standards at an accredited laboratory; sterile and measuring devices carry additional validation.
- Register and file on the CDSCO Online (SUGAM) portalCreate the account, pay the government fee online and upload the full dossier under the correct form.
- Site audit / inspectionNotified-Body audit for Class A/B manufacture; CDSCO joint-team inspection for Class C/D and, where ordered, for overseas sites on import.
- Respond to queries and receive the licenceAnswer the deficiency letter within the stipulated period; on approval the licence issues in Form MD-5 / MD-9 (manufacture) or MD-15 (import).
💰 Government Fees
Fees are set in the Second Schedule of the Medical Devices Rules and paid online through the CDSCO portal. They differ sharply by route and class:
Manufacture — Class C (Form MD-9)
Rs 50,000 per site plus Rs 1,000 for each distinct device, to the Central Licensing Authority (CDSCO headquarters).
Import (Form MD-15)
Charged per site and per device and paid in USD; for a Class C device it is among the higher import slabs, so budget by the number of sites and distinct devices.
Test licence (Form MD-13)
A modest fee for importing or making a small quantity for testing, evaluation, demonstration or clinical investigation.
Retention
Licences do not expire, but a retention fee equal to the licence fee is payable every five years to keep the licence alive.
Import fees under Form MD-15 run from roughly USD 1,000 per site plus USD 50 per device for lower-risk devices to about USD 3,000 per site plus USD 1,500 per device for Class C and D. Always confirm the current figure on the CDSCO portal before you file, as the schedule is revised from time to time.
⏱️ Timeline & Validity at a Glance
The single biggest lever on timeline is the quality of the first submission: every deficiency letter effectively restarts the clock, so a dossier that pre-empts the common objections is worth far more than one filed quickly and corrected later. Unlike the old registration certificates, an MDR 2017 licence does not carry an expiry date — it stays valid as long as the retention fee is paid every five years and the conditions of licence are met.
⚠️ Where Surgical Staplers Applications Get Queried
For Class C surgical devices with an implanted component, the recurring query reasons are:
- Staple-line integrity or staple-formation data missing.
- Implanted-staple biocompatibility or material certificates absent.
- Reload-compatibility/colour-coding not evidenced.
- Sterilisation validation not matching the actual cycle.
- Free Sale Certificate scope not covering the system/reloads on import.
🔗 Related Approvals Alongside CDSCO
A CDSCO device licence rarely travels alone. Depending on the device and the business, plan for these adjacent approvals in parallel, because any one of them can hold a consignment at the port or stop a sale even when the CDSCO licence is in order:
- Importer-Exporter Code (DGFT) — mandatory for any importer of record before the first consignment.
- Wholesale / sale licence (Form 20B / 21B, or Form MD-42) — for stocking and distributing the device in India; the Indian Authorised Agent for an import licence must already hold one.
- Legal Metrology (LMPC) registration — importers of pre-packaged devices declare MRP, net quantity, importer details and country of origin on the pack.
- BIS certification — where the device or its electrical components fall under a mandatory BIS/CRS scheme (for example many electro-medical devices).
✅ Post-Approval Obligations
The licence is the start of an ongoing compliance duty, not the end of it. After grant, the licensee must:
- Print the licence number on the label and keep the Essential Principles conformity current.
- Operate a Post-Market Surveillance (PMS) system and file the Periodic Safety Update Report (PSUR) on the schedule for the device's class.
- Report adverse events and field safety corrective actions through the Materiovigilance Programme of India (MvPI) and to CDSCO within the prescribed timelines.
- Report any change in device, materials, site, labelling or QMS, and any regulatory action or recall in another country, and act on it.
- Retain distribution records for traceability and allow CDSCO to draw samples and inspect the premises.
- Pay the retention fee every five years to keep the licence in force, and track BIS/ISO standard revisions.
❓ Frequently Asked Questions
What CDSCO class is a surgical stapler?
A surgical stapler is Class C, so a domestic manufacturer files Form MD-7 for an MD-9 licence with the Central Licensing Authority, and an importer files Form MD-14 for an MD-15 licence.
What evidence does a surgical stapler need?
Mechanical performance (staple formation, firing force, staple-line integrity/leak), implant-material biocompatibility for the staples, validated sterilisation and reload compatibility.
Are the reload cartridges registered too?
The stapler and its compatible reloads are declared together, with reload compatibility and tissue-thickness guidance evidenced to prevent staple-line failure.
Is a site inspection required?
Yes — for Class C manufacture, a CDSCO joint audit team inspects the site before the MD-9 licence is granted.
How long does registration take?
Budget roughly six to nine months for a complete Class C manufacturing (MD-9) or import (MD-15) file.
Does the licence expire?
No — the MDR 2017 licence is perpetual, subject to the five-yearly retention fee and continued compliance.
Surgical Staplers — CDSCO Licensing Handled End to End
Global Approbation manages the complete CDSCO medical-device process for surgical staplers — classification, standard mapping, Device and Plant Master File preparation, ISO 13485 and Essential Principles readiness, SUGAM filing, audit support and query response — so your licence issues without avoidable delay.
Talk to Our CDSCO Team Global Market Access